Home
| Home |
Navigator |
NAVIGATOR is intended to promote groundbreaking scientific research by our finest investigators; collaboration, resource-sharing, and cost-effectiveness; and balance between scientific, clinical, and psychosocial research.
Navigator Research Awards All-important seed funding for innovative scientific and pre-clinical research projects, directed by Canada�s most respected investigators.
Landmark Training Awards Fostering our most outstanding young scientific and clinical investigators, and permitting them to pursue HD research projects under the direction of senior investigators offered in partnership with the Canadian Institutes of Health Research.
ETA Grants Promoting Canadian participation in international initiatives, the exchange of ideas and expertise, and the development of new collaborative ventures.
Map Grants Building Canadian expertise and international collaboration in providing core research resources in such key areas as tissue banking, imaging, biostatistical analysis, and animal models.
Clinical Research Group Cultivating excellence in clinical care for HD, including our understanding of the psychosocial dimensions of the disease, while building the Canadian infrastructure for clinical investigation and for delivering new therapies to patients.
For the past 25 years, the Huntington Society has pursued the compelling vision of a brighter tomorrow for everyone affected by Huntington disease. Through its Canada-wide network of volunteers and professionals, the Society ensures that help and support are available to those in need. And now, through its new NAVIGATOR programme, the Society has set its sights on the ultimate prize - a cure for HD. I am convinced that success is within reach, and that NAVIGATOR will help us win the fight against Huntington disease.
Beginning in 1999-2000, the Huntington Society will offer at least one Navigator Research Award.
The goal of HSC Navigator Research Awards is to facilitate, through seed funding, the preliminary investigation of innovative approaches to HD science. It is expected that encouraging results will provide the basis for full-scale applications to larger funding agencies such as the Medical Research Council of Canada.
Navigator awards are also intended to promote the development of the HD research collaborations in Canada and internationally, and to enlist new investigators to the field.
Navigator Research Awards are awarded in amounts up to a maximum of $25,000, contingent on review of the budget proposed by the applicant.
Grants are made for a period of one year and are non-renewable. Only in exceptional circumstances will the Research Council consider an application for additional funding.
Individuals holding a full-time faculty appointment in an appropriate discipline at a Canadian university, research institute, or hospital are eligible to apply for Navigator Research Awards.
No investigator may hold more than one Navigator Award at the same time.
Applications will be accepted in response to requests for proposals only.
Applications must be received no later than 5:00 PM on the deadline date. Late and/or incomplete applications will be returned to the applicant.
HSC Navigator Research Award application guidelines are available on request from the office of the Huntington Society of Canada.
Applications for Navigator Research Award are subject to review by the Huntington Society�s Research Council, and by two external reviewers with expertise in the appropriate area.
The criteria for evaluating applications are:
(a) Institutional approvals. Institutional approvals for research involving humans, animals, and/or biohazardous materials must be submitted to the Huntington Society prior to the release of funding.
(b) Expenditure of funds. Funds awarded through a Navigator grant must be expended in accordance with the approved budget, within the following categories:
Funds may not be allocated to salary support for graduate or post-graduate students, institutional overheads, construction, or equipment.
(c) Payment of grants. Navigator grants will be paid in accordance with the terms stipulated in the award letter to the financial officer of the principal investigator�s institution.
(d) Overexpenditure. The Huntington Society of Canada is not responsible for any overexpenditure incurred by a grantee.
(e) Unexpended funds. Any unexpended funds must be returned to the Huntington Society of Canada on completion of the period of the grant, unless the Society approves, in advance, an extension to the term of the grant.
(f) Financial reporting. All grantees must provide a financial statement within three months of the completion of the period of the grant.
(g) Research reporting. All grantees must provide a brief summary, in lay language, of the results of their work, on completion of the period of the grant. In addition, grantees are encouraged to respond favourably if invited to address a volunteer meeting sponsored by the Huntington Society or its chapters.
Landmark Training Awards
ETA Grants
Map Grants
Clinical Research Group
General Guidelines
NEW PARTNERSHIP AWARDS FOR 2001-2002
HSC partners with the Canadian Institutes of Health Research to offer post-doctoral and
pre-doctoral awards for 2001-2002
The Huntington Society of Canada is proud to join with the Canadian Institutes of Health Research in offering one new post-doctoral award and one new pre-doctoral award for 2001-2002.
These awards are available to candidates pursuing full-time research into Huntington disease at a Canadian research institution. The post-doctoral award is valued at $35,000 per year, plus an annual research and travel allowance of $3,500; the pre-doctoral award is valued at $19,030 per year, plus an annual research and travel allowance of $500.
| Deadlines: | Post-doctoral fellowships | 1 November 2000 |
| Doctoral research awards | 15 October 2000 |
Funding will commence on 1 July 2001.
For further information and application packages, please visit the Canadian Institutes of Health Research at http://www.cihr.ca/funding_opportunities/cihr_funding_pgms/req_for_proposal/rfa-hsc_e.shtml.
Navigator Research Awards
ETA Grants
Map Grants
Clinical Research Group
General Guidelines
Beginning in 1999-2000, the Huntington Society will offer a limited number of ETA grants.
The ETA (Estimated Time of Arrival) initiative is designed to promote, through travel grants, Canadian participation in international conferences, workshops, and symposia; the exchange of ideas and expertise relevant to Huntington disease research; and the development of new collaborative ventures within Canada and internationally.
ETA grants are awarded following review of the applicant�s budget, in amounts up to $1,000.
The following parties are eligible to apply for a maximum of one ETA grant per year:
Preference will be given to applicants currently holding Landmark Training Awards who will be playing an active role - for example, presenting an abstract or poster - at a conference or meeting.
Applications are accepted throughout the year.
Grants are made on a discretionary basis, and subject to the availability of funds. Applicants may wish to consult the Huntington Society prior to submitting an application.
Application is by way of a letter which must be submitted in advance of the conference or meeting in question. The following information must be included:
ETA grants will be awarded on a discretionary basis, subject to the availability of funds, following consultation between the Chair of the Research Council and the Executive Director.
(a) Payment of grants. Grants are awarded in a single payment following review of the application.
(b) Expenditure/return of funds. Receipts must be submitted immediately following the meeting for which the award was made, and any unexpended funds must be returned promptly to the Huntington Society of Canada.
(c) Following the meeting, individuals receiving an ETA grant are required to submit a one-page report, in lay language, providing highlights of the conference or meeting they attended, and summarizing their own role in the meeting.
Navigator Research Awards
Landmark Training Awards
Map Grants
Clinical Research Group
General Guidelines
Map grants are designed to promote Canadian expertise and international collaboration in the development and enhancement of research resources which are vital to the investigation of Huntington disease - examples would include tissue banking, high-throughput screening facilities, medical imaging, biostatistical analysis, and animal models. Map grants can be awarded either as:
Map Conference Grants are one-time only awards capped at $2,500; Map Core Grants are capped at $4,000 and may be considered for renewal on an annual basis.
Principal investigators funded through any of the following initiatives are eligible to apply for Map grants:
Applications are accepted throughout the year. Grants are made on a first-come, first-served basis, subject to the availability of funds, and applicants may wish to consult the Huntington Society prior to submitting an application.
Application is by way of a letter, which must provide the following information:
(a) Map Conference Grant
(b) Map Core Grant
Map Conference grants are awarded on a discretionary basis, subject to the availability of funds, following consultation between the Chair of the Research Council and the Executive Director.
For Map Core Grants, initial submissions and subsequent renewals are reviewed by the Research Council.
(a) Payment of grants. Grants are awarded in a single payment following review of the application.
(b) Overexpenditure. The Huntington Society of Canada is not responsible for any overexpenditure incurred by a grantee.
(c) Expenditure/return of funds.
(d) Research reporting. The Huntington Society of Canada will receive a copy of all materials (proceedings, annual reports) produced pursuant to a Map grant. In addition, grantees will be required to provide a brief report, in lay language, providing highlights of the conference or project funded.
Navigator Research Awards
Landmark Training Awards
ETA Grants
Clinical Research Group
General Guidelines
In 1999-2000 the Huntington Society will provide ongoing support to the Huntington Study Group through the Clinical Research Group programme. Plans call for additional grants to be offered in future years.
Navigator Research Awards
Landmark Training Awards
ETA Grants
Map Grants
General Guidelines
All grants are subject to the availability of funds.
Applications for support must be received no later than 5:00 PM on the appropriate deadline date. Late and/or incomplete applications will be returned to the applicant. Applications will not be accepted by fax or computer diskette.
| Grant | Deadline |
| Deadline Navigator Research Awards | RFP basis |
| Landmark Fellowship Awards (HSC/CIHR) | 1 November 2000 |
| Landmark Graduate Awards (HSC/CIHR) | 15 October 2000 |
| ETA Grants | At any time |
| Map Grants | At any time |
| Clinical Research Group | n/a |
All applications for support are subject to competitive review by the Research Council and, where appropriate, by external reviewers. Applications for Landmark Training Awards are reviewed by the appropriate CIHR panel, and must be approved by the Society's Research Council.
All grants involving the use of animals require that principal investigators provide undertakings that they subscribe to the standards of the Canadian Council on Animal Care and of the host institution.
Grant funding will not be released prior to the submission of all requisite certifications, including institutional approvals relating to research involving human subjects; research involving animals; and research involving biohazardous materials.
The Huntington Society of Canada should be acknowledged in all publications, presentations, and other public information relating to research supported in whole or in part by the Society.
The Huntington Society of Canada reserves the right to participate in the royalty stream from patentable discoveries arising from research funded in whole or in part by the Society.